{"transactions":[{"id":4637641,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-10-08T01:35:02.000Z","date":"2026-10-06","kind":"exercise","planned":false,"acquired":false,"shares":65584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following ten quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following ten quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":590249,"derivative":{"underlying":"Common Stock","underlying_shares":65584},"source":{"system":"sec-edgar","filing":"0001493152-26-046202","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1993292/000149315226046202/ownership.xml","form_type":"4"}},{"id":4637640,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-10-08T01:35:02.000Z","date":"2026-10-06","kind":"exercise","planned":false,"acquired":false,"shares":2555266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":5110534,"derivative":{"underlying":"Common Stock","underlying_shares":2555266},"source":{"system":"sec-edgar","filing":"0001493152-26-046202","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1993292/000149315226046202/ownership.xml","form_type":"4"}},{"id":4637639,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-08T01:35:02.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1031102,"price":1.49,"value":1536341.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares of common stock the Issuer has withheld to satisfy the Reporting Person's income tax withholding and remittance obligations as part of the settlement of vested RSUs. Accordingly, no shares of common stock will be sold in the public market to satisfy such income tax withholding and remittance obligations associated with the settlement of these vested RSUs."}],"balance_after":1683757,"source":{"system":"sec-edgar","filing":"0001493152-26-046202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1993292/000149315226046202/ownership.xml","form_type":"4"}},{"id":4637638,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-08T01:35:02.000Z","date":"2026-10-06","kind":"exercise","planned":false,"acquired":true,"shares":2620850,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."}],"balance_after":2714859,"source":{"system":"sec-edgar","filing":"0001493152-26-046202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993292/000149315226046202/ownership.xml","form_type":"4"}},{"id":712547,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-08T22:52:59.000Z","date":"2026-07-06","kind":"exercise","planned":false,"acquired":false,"shares":131167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":655833,"derivative":{"underlying":"Common Stock","underlying_shares":131167},"source":{"system":"sec-edgar","filing":"0001493152-26-032561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032561/ownership.xml","form_type":"4"}},{"id":712546,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-08T22:52:59.000Z","date":"2026-07-07","kind":"sale","planned":false,"acquired":false,"shares":51880,"price":2.0535,"value":106535.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.045 to $2.06, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":94009,"source":{"system":"sec-edgar","filing":"0001493152-26-032561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032561/ownership.xml","form_type":"4"}},{"id":712545,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-08T22:52:59.000Z","date":"2026-07-06","kind":"exercise","planned":false,"acquired":true,"shares":131167,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 9, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 9, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,459 shares acquired under the Issuer's Employee Stock Purchase Plan on May 20, 2026."}],"balance_after":145889,"source":{"system":"sec-edgar","filing":"0001493152-26-032561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032561/ownership.xml","form_type":"4"}},{"id":904952,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-14T01:10:12.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":16000,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001493152-26-006833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226006833/ownership.xml","form_type":"4"}},{"id":904951,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-14T01:10:12.000Z","date":"2026-02-12","kind":"sale","planned":false,"acquired":false,"shares":1989,"price":1.75,"value":3480.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs."}],"balance_after":13263,"source":{"system":"sec-edgar","filing":"0001493152-26-006833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226006833/ownership.xml","form_type":"4"}},{"id":904950,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-14T01:10:12.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":true,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 11, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,400 shares acquired under the Issuer's Employee Stock Purchase Plan on November 20, 2025."}],"balance_after":15252,"source":{"system":"sec-edgar","filing":"0001493152-26-006833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226006833/ownership.xml","form_type":"4"}},{"id":909805,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T22:34:45.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":787000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":787000,"derivative":{"underlying":"Common Stock","underlying_shares":787000},"source":{"system":"sec-edgar","filing":"0001493152-26-006257","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226006257/ownership.xml","form_type":"4"}},{"id":1021376,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-08T21:41:43.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":7665800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":7665800,"derivative":{"underlying":"Common Stock","underlying_shares":7665800},"source":{"system":"sec-edgar","filing":"0001493152-25-017477","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225017477/ownership.xml","form_type":"4"}},{"id":1046759,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Phantom Units","published_at":"2025-09-05T13:00:35.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":289000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan."}],"balance_after":289000,"derivative":{"underlying":"Common Stock","underlying_shares":289000},"source":{"system":"sec-edgar","filing":"0001493152-25-012691","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225012691/ownership.xml","form_type":"4"}},{"id":1269464,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-13T22:58:18.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":24000,"derivative":{"underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001493152-25-006500","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225006500/ownership.xml","form_type":"4"}},{"id":1269463,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T22:58:18.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period with vesting commencing on May 11, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":29000,"derivative":{"exercise_price":1.13,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":29000},"source":{"system":"sec-edgar","filing":"0001493152-25-006500","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225006500/ownership.xml","form_type":"4"}},{"id":1497704,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-30T23:44:33.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":false,"shares":1555,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1555},"source":{"system":"sec-edgar","filing":"0001493152-24-022038","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224022038/ownership.xml","form_type":"4"}},{"id":1497703,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-30T23:44:33.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":false,"shares":2735,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2735},"source":{"system":"sec-edgar","filing":"0001493152-24-022038","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224022038/ownership.xml","form_type":"4"}},{"id":1497702,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:33.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":461,"price":4.76,"value":2194.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."}],"balance_after":3852,"source":{"system":"sec-edgar","filing":"0001493152-24-022038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224022038/ownership.xml","form_type":"4"}},{"id":1497701,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:33.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":true,"shares":1555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."}],"balance_after":4313,"source":{"system":"sec-edgar","filing":"0001493152-24-022038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224022038/ownership.xml","form_type":"4"}},{"id":1497700,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:33.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":810,"price":4.76,"value":3855.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."}],"balance_after":2758,"source":{"system":"sec-edgar","filing":"0001493152-24-022038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224022038/ownership.xml","form_type":"4"}},{"id":1497699,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:33.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":true,"shares":2735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."}],"balance_after":3568,"source":{"system":"sec-edgar","filing":"0001493152-24-022038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224022038/ownership.xml","form_type":"4"}},{"id":1523180,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-08T22:37:54.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":false,"shares":156,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":1555,"derivative":{"underlying":"Common Stock","underlying_shares":156},"source":{"system":"sec-edgar","filing":"0001493152-24-018284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018284/ownership.xml","form_type":"4"}},{"id":1523179,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-08T22:37:54.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":false,"shares":304,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":2735,"derivative":{"underlying":"Common Stock","underlying_shares":304},"source":{"system":"sec-edgar","filing":"0001493152-24-018284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018284/ownership.xml","form_type":"4"}},{"id":1523178,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:37:54.000Z","date":"2024-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":47,"price":8.46,"value":397.62,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."}],"balance_after":833,"source":{"system":"sec-edgar","filing":"0001493152-24-018284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018284/ownership.xml","form_type":"4"}},{"id":1523177,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:37:54.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":true,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."}],"balance_after":880,"source":{"system":"sec-edgar","filing":"0001493152-24-018284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018284/ownership.xml","form_type":"4"}},{"id":1523176,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:37:54.000Z","date":"2024-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":90,"price":8.46,"value":761.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."}],"balance_after":724,"source":{"system":"sec-edgar","filing":"0001493152-24-018284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018284/ownership.xml","form_type":"4"}},{"id":1523175,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:37:54.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":true,"shares":304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."}],"balance_after":814,"source":{"system":"sec-edgar","filing":"0001493152-24-018284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018284/ownership.xml","form_type":"4"}},{"id":1653249,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-08T21:38:32.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":2333,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"This restricted stock unit was granted on November 21, 2023, and 2,333 restricted stock units subject to the award vested on February 6, 2024, and an additional 25,667 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"This restricted stock unit was granted on November 21, 2023, and 2,333 restricted stock units subject to the award vested on February 6, 2024, and an additional 25,667 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This restricted stock unit was granted on November 21, 2023, and 2,333 restricted stock units subject to the award vested on February 6, 2024, and an additional 25,667 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":25667,"derivative":{"underlying":"Common Stock","underlying_shares":2333},"source":{"system":"sec-edgar","filing":"0001493152-24-005482","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224005482/ownership.xml","form_type":"4"}},{"id":1653248,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2024-02-08T21:38:32.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":false,"shares":4558,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"This restricted stock unit was granted on September 5, 2023, and 4,558 restricted stock units subject to the award vested on February 6, 2024, and an additional 45,586 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This restricted stock unit was granted on September 5, 2023, and 4,558 restricted stock units subject to the award vested on February 6, 2024, and an additional 45,586 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This restricted stock unit was granted on September 5, 2023, and 4,558 restricted stock units subject to the award vested on February 6, 2024, and an additional 45,586 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":45586,"derivative":{"underlying":"Common Stock","underlying_shares":4558},"source":{"system":"sec-edgar","filing":"0001493152-24-005482","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224005482/ownership.xml","form_type":"4"}},{"id":1653247,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-08T21:38:32.000Z","date":"2024-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":2153,"price":0.4361,"value":938.9233,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units for each of the vested portions of the grant."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units for each of the vested portions of the grant."}],"balance_after":7662,"source":{"system":"sec-edgar","filing":"0001493152-24-005482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224005482/ownership.xml","form_type":"4"}},{"id":1653246,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-08T21:38:32.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":2333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."}],"balance_after":9815,"source":{"system":"sec-edgar","filing":"0001493152-24-005482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224005482/ownership.xml","form_type":"4"}},{"id":1653245,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-08T21:38:32.000Z","date":"2024-02-06","kind":"exercise","planned":false,"acquired":true,"shares":4558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."}],"balance_after":7482,"source":{"system":"sec-edgar","filing":"0001493152-24-005482","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224005482/ownership.xml","form_type":"4"}},{"id":1730216,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Options","published_at":"2023-11-24T21:00:16.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":33160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Grants were made as discretionary grants to Reporting Person from the Issuer's 2021 Equity Incentive Plan, as amended (\"Plan\"). Pursuant to Nasdaq rules, no shares may be issued pursuant to the grants until such time as there are sufficient shares of common stock available under the Plan. The applicable vesting for each grant is subject to the Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"security","element":"securityTitle","label":"F5","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F6","text":"The grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The grant vests in twelve (12) equal quarterly installments over a three (3) year period from the grant date."}],"balance_after":33160,"derivative":{"exercise_price":0.59,"expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":33160},"source":{"system":"sec-edgar","filing":"0001493152-23-042664","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223042664/ownership.xml","form_type":"4"}},{"id":1730215,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-11-24T21:00:16.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Grants were made as discretionary grants to Reporting Person from the Issuer's 2021 Equity Incentive Plan, as amended (\"Plan\"). Pursuant to Nasdaq rules, no shares may be issued pursuant to the grants until such time as there are sufficient shares of common stock available under the Plan. The applicable vesting for each grant is subject to the Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"security","element":"securityTitle","label":"F3","text":"The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The grant vests in twelve (12) equal quarterly installments over a three (3) year period with the first vesting date to occur on February 6, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"N/A."}],"balance_after":28000,"derivative":{"underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001493152-23-042664","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223042664/ownership.xml","form_type":"4"}},{"id":1746637,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-11-08T22:01:05.000Z","date":"2023-11-06","kind":"exercise","planned":false,"acquired":false,"shares":4556,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit was granted on September 5, 2023, and 4,556 restricted stock units subject to the award vested on November 6, 2023, and an additional 50,144 restricted stock units will vest in equal installments over the eleven (11) quarterly periods thereafter, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit was granted on September 5, 2023, and 4,556 restricted stock units subject to the award vested on November 6, 2023, and an additional 50,144 restricted stock units will vest in equal installments over the eleven (11) quarterly periods thereafter, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."}],"balance_after":50144,"derivative":{"underlying":"Common Stock","underlying_shares":4556},"source":{"system":"sec-edgar","filing":"0001493152-23-039935","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223039935/ownership.xml","form_type":"4"}},{"id":1746636,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2023-11-08T22:01:05.000Z","date":"2023-11-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1630,"price":0.5389,"value":878.407,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units."}],"balance_after":2926,"source":{"system":"sec-edgar","filing":"0001493152-23-039935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223039935/ownership.xml","form_type":"4"}},{"id":1746635,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2023-11-08T22:01:05.000Z","date":"2023-11-06","kind":"exercise","planned":false,"acquired":true,"shares":4556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units."}],"balance_after":4556,"source":{"system":"sec-edgar","filing":"0001493152-23-039935","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315223039935/ownership.xml","form_type":"4"}}]}